NOX 0.00% 8.0¢ noxopharm limited

Ann: mRNA Vaccine Enhancer Shows Inflammation Reduction, page-46

  1. 5 Posts.
    lightbulb Created with Sketch. 2
    The rationale was explained at the AGM. mRNA vaccines or drugs induce inflammation courtesy of the TLR-7 receptor. Moderna and Pfizer/BioNTech have exclusive licence to the technology invented by the two recent Nobel Prize winners to help block the inflammatory response. All other companies interested in mRNA vaccines or drugs have been locked out of that technology and need to find another way to allow them onto the market. NOX believes that it has the only other way. So, I take it from that explanation that prospective Licensees are everyone else apart from Moderna and Pfizer/BioNTech.
 
watchlist Created with Sketch. Add NOX (ASX) to my watchlist
(20min delay)
Last
8.0¢
Change
0.000(0.00%)
Mkt cap ! $23.37M
Open High Low Value Volume
8.2¢ 8.2¢ 8.0¢ $5.491K 68.10K

Buyers (Bids)

No. Vol. Price($)
2 147568 8.0¢
 

Sellers (Offers)

Price($) Vol. No.
8.2¢ 46145 2
View Market Depth
Last trade - 14.31pm 05/06/2024 (20 minute delay) ?
Last
8.2¢
  Change
0.000 ( 5.13 %)
Open High Low Volume
8.2¢ 8.2¢ 8.2¢ 30000
Last updated 11.56am 05/06/2024 ?
NOX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.